ConCallIQ
Go Pro
SYNGENEINTERNATIONAL Diversified 2026-04-??

Syngene International Ltd — Q4 FY26

Syngene reported Q4 FY26 revenue of ₹1,037 crore (+2% YoY, +13% QoQ) and EBITDA margin of 29%, beating revised guidance.

neutral medium
Compare with...
Revenue ₹1,036 Cr +2%
EBITDA ₹303 Cr
PAT ₹148 Cr -16%
EBITDA Margin 29% -500bps
Duration
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Librella destocking impact

Librella revenue decline will continue to pressure revenue in H1 FY27, with near-zero contribution in Q1 and Q2.

high · management_commentary
R

Bay View facility cost drag

Bay View costs are only partially capitalized; full impact on P&L not yet known, potentially pressuring margins.

medium · analyst_question
R

Geopolitical and tariff risks

Section 232 tariffs on pharma products could slow CDMO order flow, though management assesses negligible impact.

low · analyst_question
R

Margin trajectory uncertainty

Management cut margin guidance mid-year but beat it; path to high-20s margins remains unclear.

medium · data_observation